Drug companies pay for exclusive access to UK genetic data

Drug companies pay for exclusive access to UK genetic data

Source: 
Biopharma Dive
snippet: 

Four of the world's largest drug companies have agreed to pay around $120 million for exclusive access to genetic data on hundreds of thousands of people.